Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,489 | -49,375 | -42,494 | -39,225 | -82,181 |
| Depreciation Amortization | -201 | 102 | -1,336 | 1,103 | 1,624 |
| Accounts payable and accrued liabilities | -664 | -1,841 | 708 | 2,515 | -194 |
| Other Working Capital | 9,179 | -4,142 | -2,908 | -1,263 | 6,245 |
| Other Operating Activity | 9,032 | 10,401 | 5,412 | 2,745 | 54,840 |
| Operating Cash Flow | $-49,143 | $-44,855 | $-40,618 | $-34,125 | $-19,666 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -93,281 | 46,816 | 26,995 | -151,164 | N/A |
| PPE Investments | -25 | -44 | -30 | -36 | -1,452 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -318 |
| Investing Cash Flow | $-93,306 | $46,772 | $26,965 | $-151,200 | $-1,770 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -9,375 |
| Common Stock Issued | 139,274 | 18,113 | 3,188 | 76,252 | 128,267 |
| Common Stock Repurchased | -8,638 | -543 | -94 | -495 | -281 |
| Other Financing Activity | -1,027 | -232 | -159 | 0 | 0 |
| Financing Cash Flow | $129,609 | $17,338 | $2,935 | $75,757 | $118,611 |
| Beginning Cash Position | 44,051 | 24,796 | 34,946 | 144,514 | 47,339 |
| End Cash Position | 31,211 | 44,051 | 24,228 | 34,946 | 144,514 |
| Net Cash Flow | $-12,840 | $19,255 | $-10,718 | $-109,568 | $97,175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,143 | -44,855 | -40,618 | -34,125 | -19,666 |
| Capital Expenditure | -25 | -44 | -30 | -212 | -1,568 |
| Free Cash Flow | -49,168 | -44,899 | -40,648 | -34,337 | -21,234 |